ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37I7956
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global and China Hepatitis Vaccine Market Insights Forecast to 2027
BUY CHAPTERS

Global Hepatitis Vaccine Market Research Report 2025

Code: QYRE-Auto-37I7956
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Sanofi
Sinovac
Zhejiang Pukang
IMBCA
Changsheng

Hepatitis Vaccine Market Size

The global market for Hepatitis Vaccine was valued at US$ 2193 million in the year 2024 and is projected to reach a revised size of US$ 2497 million by 2031, growing at a CAGR of 1.9% during the forecast period.

Hepatitis Vaccine Market

Hepatitis Vaccine Market

Hepatitis vaccine is a vaccine that prevents hepatitis
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Vaccine.
The Hepatitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hepatitis Vaccine Market Report

Report Metric Details
Report Name Hepatitis Vaccine Market
Accounted market size in year US$ 2193 million
Forecasted market size in 2031 US$ 2497 million
CAGR 1.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Children
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences, Serum Institute, Sanofi, Sinovac, Zhejiang Pukang, IMBCA, ChangSheng
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hepatitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hepatitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hepatitis Vaccine Market growing?

Ans: The Hepatitis Vaccine Market witnessing a CAGR of 1.9% during the forecast period 2025-2031.

What is the Hepatitis Vaccine Market size in 2031?

Ans: The Hepatitis Vaccine Market size in 2031 will be US$ 2497 million.

Who are the main players in the Hepatitis Vaccine Market report?

Ans: The main players in the Hepatitis Vaccine Market are GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences, Serum Institute, Sanofi, Sinovac, Zhejiang Pukang, IMBCA, ChangSheng

What are the Application segmentation covered in the Hepatitis Vaccine Market report?

Ans: The Applications covered in the Hepatitis Vaccine Market report are Children, Adult

What are the Type segmentation covered in the Hepatitis Vaccine Market report?

Ans: The Types covered in the Hepatitis Vaccine Market report are Hepatitis A Vaccines, Hepatitis B Vaccines

Recommended Reports

Vaccines and Immunization

Liver Diseases Therapeutics

Vaccine Logistics Solutions

1 Hepatitis Vaccine Market Overview
1.1 Product Definition
1.2 Hepatitis Vaccine by Type
1.2.1 Global Hepatitis Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hepatitis A Vaccines
1.2.3 Hepatitis B Vaccines
1.3 Hepatitis Vaccine by Application
1.3.1 Global Hepatitis Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hepatitis Vaccine Revenue 2020-2031
1.4.2 Global Hepatitis Vaccine Sales 2020-2031
1.4.3 Global Hepatitis Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hepatitis Vaccine Market Competition by Manufacturers
2.1 Global Hepatitis Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hepatitis Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hepatitis Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hepatitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Hepatitis Vaccine, Date of Enter into This Industry
2.8 Global Hepatitis Vaccine Market Competitive Situation and Trends
2.8.1 Global Hepatitis Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hepatitis Vaccine Players Market Share by Revenue
2.8.3 Global Hepatitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hepatitis Vaccine Market Scenario by Region
3.1 Global Hepatitis Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hepatitis Vaccine Sales by Region: 2020-2031
3.2.1 Global Hepatitis Vaccine Sales by Region: 2020-2025
3.2.2 Global Hepatitis Vaccine Sales by Region: 2026-2031
3.3 Global Hepatitis Vaccine Revenue by Region: 2020-2031
3.3.1 Global Hepatitis Vaccine Revenue by Region: 2020-2025
3.3.2 Global Hepatitis Vaccine Revenue by Region: 2026-2031
3.4 North America Hepatitis Vaccine Market Facts & Figures by Country
3.4.1 North America Hepatitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hepatitis Vaccine Sales by Country (2020-2031)
3.4.3 North America Hepatitis Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Hepatitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hepatitis Vaccine Sales by Country (2020-2031)
3.5.3 Europe Hepatitis Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Hepatitis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hepatitis Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Hepatitis Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Hepatitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hepatitis Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Hepatitis Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hepatitis Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hepatitis Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis Vaccine Sales by Type (2020-2031)
4.1.1 Global Hepatitis Vaccine Sales by Type (2020-2025)
4.1.2 Global Hepatitis Vaccine Sales by Type (2026-2031)
4.1.3 Global Hepatitis Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Hepatitis Vaccine Revenue by Type (2020-2031)
4.2.1 Global Hepatitis Vaccine Revenue by Type (2020-2025)
4.2.2 Global Hepatitis Vaccine Revenue by Type (2026-2031)
4.2.3 Global Hepatitis Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Hepatitis Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hepatitis Vaccine Sales by Application (2020-2031)
5.1.1 Global Hepatitis Vaccine Sales by Application (2020-2025)
5.1.2 Global Hepatitis Vaccine Sales by Application (2026-2031)
5.1.3 Global Hepatitis Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Hepatitis Vaccine Revenue by Application (2020-2031)
5.2.1 Global Hepatitis Vaccine Revenue by Application (2020-2025)
5.2.2 Global Hepatitis Vaccine Revenue by Application (2026-2031)
5.2.3 Global Hepatitis Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Hepatitis Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Hepatitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Company Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 NCPC Hepatitis Vaccine Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Hepatitis Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Company Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bio Kangtai Hepatitis Vaccine Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Company Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dynavax Hepatitis Vaccine Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 Hissen
6.6.1 Hissen Company Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hissen Hepatitis Vaccine Product Portfolio
6.6.5 Hissen Recent Developments/Updates
6.7 KM Biologics
6.7.1 KM Biologics Company Information
6.7.2 KM Biologics Description and Business Overview
6.7.3 KM Biologics Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 KM Biologics Hepatitis Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Company Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LG Life Sciences Hepatitis Vaccine Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Company Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Serum Institute Hepatitis Vaccine Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Company Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi Hepatitis Vaccine Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Sinovac
6.11.1 Sinovac Company Information
6.11.2 Sinovac Description and Business Overview
6.11.3 Sinovac Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sinovac Hepatitis Vaccine Product Portfolio
6.11.5 Sinovac Recent Developments/Updates
6.12 Zhejiang Pukang
6.12.1 Zhejiang Pukang Company Information
6.12.2 Zhejiang Pukang Description and Business Overview
6.12.3 Zhejiang Pukang Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Pukang Hepatitis Vaccine Product Portfolio
6.12.5 Zhejiang Pukang Recent Developments/Updates
6.13 IMBCA
6.13.1 IMBCA Company Information
6.13.2 IMBCA Description and Business Overview
6.13.3 IMBCA Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 IMBCA Hepatitis Vaccine Product Portfolio
6.13.5 IMBCA Recent Developments/Updates
6.14 ChangSheng
6.14.1 ChangSheng Company Information
6.14.2 ChangSheng Description and Business Overview
6.14.3 ChangSheng Hepatitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 ChangSheng Hepatitis Vaccine Product Portfolio
6.14.5 ChangSheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis Vaccine Industry Chain Analysis
7.2 Hepatitis Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis Vaccine Production Mode & Process Analysis
7.4 Hepatitis Vaccine Sales and Marketing
7.4.1 Hepatitis Vaccine Sales Channels
7.4.2 Hepatitis Vaccine Distributors
7.5 Hepatitis Vaccine Customer Analysis
8 Hepatitis Vaccine Market Dynamics
8.1 Hepatitis Vaccine Industry Trends
8.2 Hepatitis Vaccine Market Drivers
8.3 Hepatitis Vaccine Market Challenges
8.4 Hepatitis Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Sanofi
Sinovac
Zhejiang Pukang
IMBCA
Changsheng
List of Tables
 Table 1. Global Hepatitis Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hepatitis Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hepatitis Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hepatitis Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hepatitis Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hepatitis Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hepatitis Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hepatitis Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hepatitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hepatitis Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hepatitis Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Hepatitis Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hepatitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hepatitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hepatitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hepatitis Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Hepatitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hepatitis Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Hepatitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hepatitis Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Hepatitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hepatitis Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Hepatitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hepatitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hepatitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hepatitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hepatitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hepatitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hepatitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hepatitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hepatitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hepatitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hepatitis Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hepatitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hepatitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hepatitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hepatitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hepatitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hepatitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hepatitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hepatitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hepatitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hepatitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hepatitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hepatitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hepatitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hepatitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hepatitis Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Hepatitis Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Hepatitis Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Hepatitis Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Hepatitis Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hepatitis Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hepatitis Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Hepatitis Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Hepatitis Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hepatitis Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hepatitis Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Hepatitis Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Hepatitis Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Hepatitis Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Hepatitis Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hepatitis Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hepatitis Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Hepatitis Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Hepatitis Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hepatitis Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Hepatitis Vaccine Product
 Table 74. GSK Recent Developments/Updates
 Table 75. NCPC Company Information
 Table 76. NCPC Description and Business Overview
 Table 77. NCPC Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. NCPC Hepatitis Vaccine Product
 Table 79. NCPC Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Hepatitis Vaccine Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Bio Kangtai Company Information
 Table 86. Bio Kangtai Description and Business Overview
 Table 87. Bio Kangtai Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bio Kangtai Hepatitis Vaccine Product
 Table 89. Bio Kangtai Recent Developments/Updates
 Table 90. Dynavax Company Information
 Table 91. Dynavax Description and Business Overview
 Table 92. Dynavax Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Dynavax Hepatitis Vaccine Product
 Table 94. Dynavax Recent Developments/Updates
 Table 95. Hissen Company Information
 Table 96. Hissen Description and Business Overview
 Table 97. Hissen Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hissen Hepatitis Vaccine Product
 Table 99. Hissen Recent Developments/Updates
 Table 100. KM Biologics Company Information
 Table 101. KM Biologics Description and Business Overview
 Table 102. KM Biologics Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. KM Biologics Hepatitis Vaccine Product
 Table 104. KM Biologics Recent Developments/Updates
 Table 105. LG Life Sciences Company Information
 Table 106. LG Life Sciences Description and Business Overview
 Table 107. LG Life Sciences Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. LG Life Sciences Hepatitis Vaccine Product
 Table 109. LG Life Sciences Recent Developments/Updates
 Table 110. Serum Institute Company Information
 Table 111. Serum Institute Description and Business Overview
 Table 112. Serum Institute Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Serum Institute Hepatitis Vaccine Product
 Table 114. Serum Institute Recent Developments/Updates
 Table 115. Sanofi Company Information
 Table 116. Sanofi Description and Business Overview
 Table 117. Sanofi Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sanofi Hepatitis Vaccine Product
 Table 119. Sanofi Recent Developments/Updates
 Table 120. Sinovac Company Information
 Table 121. Sinovac Description and Business Overview
 Table 122. Sinovac Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sinovac Hepatitis Vaccine Product
 Table 124. Sinovac Recent Developments/Updates
 Table 125. Zhejiang Pukang Company Information
 Table 126. Zhejiang Pukang Description and Business Overview
 Table 127. Zhejiang Pukang Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Zhejiang Pukang Hepatitis Vaccine Product
 Table 129. Zhejiang Pukang Recent Developments/Updates
 Table 130. IMBCA Company Information
 Table 131. IMBCA Description and Business Overview
 Table 132. IMBCA Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. IMBCA Hepatitis Vaccine Product
 Table 134. IMBCA Recent Developments/Updates
 Table 135. ChangSheng Company Information
 Table 136. ChangSheng Description and Business Overview
 Table 137. ChangSheng Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. ChangSheng Hepatitis Vaccine Product
 Table 139. ChangSheng Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Hepatitis Vaccine Distributors List
 Table 143. Hepatitis Vaccine Customers List
 Table 144. Hepatitis Vaccine Market Trends
 Table 145. Hepatitis Vaccine Market Drivers
 Table 146. Hepatitis Vaccine Market Challenges
 Table 147. Hepatitis Vaccine Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hepatitis Vaccine
 Figure 2. Global Hepatitis Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hepatitis Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Hepatitis A Vaccines Product Picture
 Figure 5. Hepatitis B Vaccines Product Picture
 Figure 6. Global Hepatitis Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hepatitis Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Children
 Figure 9. Adult
 Figure 10. Global Hepatitis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Hepatitis Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Hepatitis Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Hepatitis Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Hepatitis Vaccine Report Years Considered
 Figure 15. Hepatitis Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Hepatitis Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Hepatitis Vaccine Players: Market Share by Revenue in Hepatitis Vaccine in 2024
 Figure 18. Hepatitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Hepatitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Hepatitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Hepatitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Hepatitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Hepatitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Hepatitis Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Hepatitis Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Hepatitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Hepatitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Hepatitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Hepatitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Hepatitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Hepatitis Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Hepatitis Vaccine by Type (2020-2031)
 Figure 54. Global Hepatitis Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Hepatitis Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Hepatitis Vaccine by Application (2020-2031)
 Figure 57. Global Hepatitis Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Hepatitis Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mono Hepatitis A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A Vaccination Market Research Report 2025
Immune Globulins Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Akabane Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bovine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Travel Vaccines Market Insights Forecast to 2030
Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis B Vaccines Market
Glass Bottle for Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions